scholarly journals Discovery to Launch of Anti-allergy (Emadine; Patanol/Pataday/Pazeo) and Anti-glaucoma (Travatan; Simbrinza) Ocular Drugs, and Generation of Novel Pharmacological Tools Such as AL-8810

2020 ◽  
Vol 3 (6) ◽  
pp. 1391-1421
Author(s):  
Najam A. Sharif
Keyword(s):  
Ocular Drugs

Biodegradable polymers for the controlled release of ocular drugs

1998 ◽  
Vol 23 (3) ◽  
pp. 563-580 ◽  
Author(s):  
A. Merkli ◽  
C. Tabatabay ◽  
R. Gurny ◽  
J. Heller
Keyword(s):  
Controlled Release ◽  
Biodegradable Polymers ◽  
Ocular Drugs

A new strategy to sustained release of ocular drugs by one-step drug-loaded microcapsule manufacturing in hydrogel punctal plugs

2017 ◽  
Vol 255 (11) ◽  
pp. 2173-2184 ◽  
Author(s):  
Jiajun Xie ◽  
Changjun Wang ◽  
Qingyao Ning ◽  
Qi Gao ◽  
Changyou Gao ◽  
...  
Keyword(s):  
Sustained Release ◽  
Punctal Plugs ◽  
New Strategy ◽  
Ocular Drugs ◽  
One Step

Systemic Effects of Ocular Drugs

1989 ◽  
pp. 843-862
Author(s):  
Robert D. Newcomb ◽  
Marlon L. Priest
Keyword(s):  
Systemic Effects ◽  
Ocular Drugs

A TEST BED FOR OCULAR DRUGS*

1986 ◽  
Vol 6 (2) ◽  
pp. 135-137 ◽  
Author(s):  
Chris Wigham ◽  
Stuart Hodson
Keyword(s):  
Test Bed ◽  
Ocular Drugs

scholarly journals The Role of Medications in Causing Dry Eye

2012 ◽  
Vol 2012 ◽  
pp. 1-8 ◽  
Author(s):  
Frederick T. Fraunfelder ◽  
James J. Sciubba ◽  
William D. Mathers
Keyword(s):  
Dry Eye ◽  
Ocular Surface ◽  
Dry Mouth ◽  
Eye Disease ◽  
Therapeutic Action ◽  
Common Cause ◽  
Complex Interactions ◽  
Ocular Drugs

The purpose of this paper is to review the possible role of polypharmacy in causing dry eye disease (DED), reflecting the complex interactions and complications associated with the use of multiple systemic and topical ocular medications. The pharmacological, physiological, anatomical, and histological mechanisms causing dry mouth differ little from those causing dry eye. Oral polypharmacy is the most common cause of dry mouth, but has not been investigated as a cause of dry eye. Topical ocular polypharmacy has been shown to cause DED. Information on drugs that likely cause or aggravate DED and the controversial role of preservatives in topical ocular medications are examined. Systemic or topical ocular medications and preservatives used in topical ocular drugs may cause dry eye through the drug's therapeutic action, ocular surface effects, or preservatives, and the effects probably are additive. Long-term use of topical ocular medications, especially those containing preservatives such as BAK, may play an important role in DED and the role of polypharmacy needs further study. We review possible ways to decrease the risk of medication-related dry eye.

Effect of the macromolecular architecture of biodegradable polyurethanes on the controlled delivery of ocular drugs

2008 ◽  
Vol 20 (2) ◽  
pp. 481-487 ◽  
Author(s):  
Gisele Rodrigues da Silva ◽  
Armando da Silva Cunha ◽  
Eliane Ayres ◽  
Rodrigo L. Oréfice
Keyword(s):  
Controlled Delivery ◽  
Ocular Drugs ◽  
Macromolecular Architecture

scholarly journals A Current Appreciation of Sites for Pharmacological Intervention in Allergic Conjunctivitis: Effects of New Topical Ocular Drugs

1999 ◽  
Vol 77 ◽  
pp. 33-37 ◽  
Author(s):  
J. M. Yanni ◽  
N. A. Sharif ◽  
D. A. Gamache ◽  
S. T. Miller ◽  
L. K. Weimer ◽  
...  
Keyword(s):  
Allergic Conjunctivitis ◽  
Pharmacological Intervention ◽  
Ocular Drugs ◽  
A Current

scholarly journals Side effects and prescription errors of ocular drugs

2010 ◽  
Vol 3 (3) ◽  
pp. 162
Author(s):  
SaqibAli Khan Utman ◽  
Astrid Specht ◽  
HannaMasud Baig
Keyword(s):  
Side Effects ◽  
Prescription Errors ◽  
Ocular Drugs

OCULAR DRUGS AND ANESTHESIA

1990 ◽  
Vol 28 (2) ◽  
pp. 72-77 ◽  
Author(s):  
Kathryn E. McGoldrick
Keyword(s):  
Ocular Drugs
Sign in / Sign up

Export Citation Format

Share Document